Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
about
Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabsAssociation between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patientsCost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.Hospital epidemiology and infection control in acute-care settings.Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococciDoes vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic reviewAnalysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Relationships between enterococcal virulence and antimicrobial resistance.Vancomycin-resistant enterococci.Factors associated with variation in estimates of the cost of resistant infectionsAntimicrobial stewardship programs in health care systems.Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococciSusceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital.Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.Vancomycin-resistant enterococci in Canada revisited.Neutrophils are essential for rapid clearance of Enterococcus faecium in miceIncidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use?Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolatesGlycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.Outcomes associated with vancomycin-resistant enterococci: a meta-analysis.Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases.Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy.Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.Risk Factors and Outcomes for Vancomycin-Resistant Enterococcus Bloodstream Infection in Children.Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.Enterococci and Their Interactions with the Intestinal Microbiome.Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality.Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections.
P2860
Q24651085-65783E08-99C2-4F0B-AF2F-80D9900CF6F3Q26751621-33224625-6933-4598-A4DE-5C7A7D3DA80EQ30309847-706501EE-E18D-4C8E-9CBF-2F374C8D8EC3Q30429049-5DEE2CC3-CE7B-44C4-81C4-25E10D355793Q33218606-C4EF137E-A228-4A0E-8577-C71B40573DDEQ33258506-C2FD5784-4B77-463E-AD4E-0758494ECE33Q33281709-5EC01C5D-9778-487D-8C2F-FED52B5A328CQ33293228-8C15258A-6CDE-454E-BC5F-9D7C8BDCDD7EQ33880518-C73AEA18-D9CC-48B1-B3B4-188B36E9AF36Q33975543-FFA9697D-B1D9-4C92-A01F-9EADF8BA6318Q33975592-26A2767F-294E-4DC6-B656-774F25EF3342Q34077002-EFFFDA94-2374-4C0C-A2FF-32F1262A3222Q34097674-F1D04EFA-1F8D-4897-9EC9-CA8981D33A41Q34192576-989A3AFB-40CB-44D1-ABDF-1070681A7A61Q34645156-AB4EA502-7941-4C48-BCE0-81A6762DCD43Q34838886-9E3C497E-48F3-4ACF-A6F3-2C2F173EE37FQ35027260-43FA3F01-9D99-4743-B4A4-5543C26E02D1Q36170170-9D3A2623-9D5A-4140-8039-245D8A0EC390Q37033050-70CDAB07-CAE2-4BEC-B362-D5B1CCC395D7Q37346968-FC4D1B42-4BE8-4440-92B6-0596DA3D88D0Q37539680-4A83A280-7855-4172-80C8-EF07E75E5A86Q38263421-060B5DE3-67E9-405B-9D2C-8DCF220096DFQ39677559-DD843142-EBA2-4574-8A16-896D9C026FB3Q40306161-01289887-220A-4261-BEEF-A8CD9AF8C6C2Q40606947-FCEA9A3C-FCE2-4140-BA08-DF4E0F27E033Q41908608-B14DB947-E538-43A8-84EA-4AB83479D204Q42218821-445AC86E-F255-4548-B62E-6A3DD5AB0CA1Q44200926-86647A9F-4400-4C84-B9BE-AE51B2E41993Q44417864-EF4AAEE7-F53E-4449-BD8B-0A612EC9BB95Q44425782-DF55CE62-835D-4408-8B13-67B7D23A474EQ44596511-7E234662-93BB-4CB0-AF55-A37FAA4EEF57Q44696137-1D45BFEC-D6B4-4C22-A5D8-84D20990A77EQ44930316-12CFCBEC-A9B3-43BF-A659-A356BAEBBF6EQ44930325-DC1F3F71-18A1-4AD2-8DB6-AC9A70DFEB4CQ46330083-6402D8B6-F4F1-49C2-8F76-E7DF394F24B5Q46639421-639B63FF-BD73-4EEB-9D63-7AE061739510Q46819823-61DB32F0-72CE-46B2-8B7A-DEF29E17ED6FQ46851724-9B78B23A-8D9D-4BFA-800A-39AD0CDAFD6FQ46914675-9CDE1014-AA17-4332-9DD3-BBB3A81710A5Q48547085-029C8E3D-E9C2-400E-B9DF-67335C5153E8
P2860
Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@en
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@nl
type
label
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@en
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@nl
prefLabel
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@en
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@nl
P2093
P2860
P356
P1476
Enterococcal bacteremia: risk ...... e and predictors of mortality.
@en
P2093
E Lautenbach
P J Brennan
W B Bilker
P2860
P304
P356
10.1086/501624
P577
1999-05-01T00:00:00Z